Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00140998 · ClinicalTrials.gov registry record · Phase 3
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
A Phase 3 study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 16
- Enrollment target
NCT00140998: Completed Phase 3 study, sponsored by Nemours Children's Clinic.
NCT00140998 is a Phase 3 study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 16 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00140998, a Phase 3 study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 16 participants
- Enrollment target
Study Summary
The study attempts to evaluate if the way of administering estrogen, the principal female hormone, via patches or orally, affects the way estrogen works in girls with Turner Syndrome. These are girls who are very short and whose ovaries do not work. We will examine changes bone, protein and fat metabolism under the influence of estrogen delivered by a patch trough the skin vs estrogen taken orally. These studies are conducted while the girls are taking GH therapy.
Interventions
- DRUG 17 beta estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2001-01 |
| Est. Completion | 2004-06 |
| Phase | Phase 3 |
What the finished NCT00140998 record still lists
NCT00140998 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which 17 beta estradiol is the first listed.
NCT00140998 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00140998 about?
NCT00140998 is a clinical study titled "Estrogen Treatment (Oral vs. Patches) in Turner Syndrome". The study attempts to evaluate if the way of administering estrogen, the principal female hormone, via patches or orally, affects the way estrogen works in girls with Turner Syndrome. These are girls who are very short and whose ovaries do not work. We will examine changes bone, protein and fat meta...
What is the current status of trial NCT00140998?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 16 participants. The study started on 2001-01. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00140998?
The interventions under investigation include: 17 beta estradiol (DRUG).
Who is sponsoring clinical trial NCT00140998?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00140998's enrollment target sits among peer trials
16 1974th of 2000 higher than 24 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia